Physician

Jason Scott Ballin, D.O.

According to 2025 Medicare claims, Jason Ballin, D.O. (NPI: 1235293820) practices dermatology in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is DERMATOLOGISTS OF SOUTHWESTERN OHIO, LLC. (NPI: 1801819883; TIN: 310964774) and primary practice location at 45415-1185.

Ballin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,345 traditional Medicare patients, billed 14,063 HCPCS/CPT codes, and received $567,382 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 3,753 prescription claims across 1,303 beneficiaries totaling $828,434 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 70 records totaling $1,281. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $37,882 to $567,382. Similarly, Part D prescription costs have moved sharply higher in recent years, from $16,664 to $828,434. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$299K$599K2017 Medicare payment: $37,882 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $200,888 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $347,630 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $414,992 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $540,066 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $539,629 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $598,945 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $567,382 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20172491,077$37,882
20188865,225$200,888
20191,3679,432$347,630
20201,18211,298$414,992
20211,20613,242$540,066
20221,28013,760$539,629
20231,29415,146$598,945
20241,34514,063$567,382

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$571K$1.1M2017 Drug cost: $16,664 (USD; Tot_Drug_Cst)2018 Drug cost: $103,999 (USD; Tot_Drug_Cst)2019 Drug cost: $327,715 (USD; Tot_Drug_Cst)2020 Drug cost: $550,699 (USD; Tot_Drug_Cst)2021 Drug cost: $791,265 (USD; Tot_Drug_Cst)2022 Drug cost: $985,458 (USD; Tot_Drug_Cst)2023 Drug cost: $1,142,915 (USD; Tot_Drug_Cst)2024 Drug cost: $828,434 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017110241$16,664
20186581,727$103,999
20191,0132,752$327,715
20209932,835$550,699
20211,1433,301$791,265
20221,0203,139$985,458
20231,1063,401$1,142,915
20241,3033,753$828,434

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths1,1161,811$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,2432,362$58
11300Shaving of skin growth of body, arms, or legs, 0.5 cm or less569916$38
17000Destruction of precancer skin growth, 1 growth9191,538$27
17003Destruction of precancer skin growth, 2-14 growths7064,854$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab12336$163,481
Cosentyx Sensoready (2 Pens)Secukinumab12336$86,980
OtezlaApremilast12360$58,958
Fluocinolone AcetonideFluocinolone Acetonide1885,674$10,464
Clobetasol PropionateClobetasol Propionate2437,106$6,849

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.70$1,281E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jason Scott Ballin, D.O.?

Tedicare shows public-source Medicare data for Jason Scott Ballin, D.O. (NPI 1235293820), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Scott Ballin, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jason Scott Ballin, D.O.?

Jason Scott Ballin, D.O. is linked to DERMATOLOGISTS OF SOUTHWESTERN OHIO, LLC. (billing NPI 1801819883) in the available physician profile data.

Does Jason Scott Ballin, D.O. have Open Payments data?

Jason Scott Ballin, D.O. has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.